Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 1 | 1 | N/A | 1 |
| Receivables | N/A | N/A | 1 | N/A | N/A |
| Inventories | 586 | 588 | 588 | N/A | 692 |
| TOTAL | $586 | $589 | $590 | $N/A | $693 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 3 | N/A | 6 |
| Intangibles | 22 | 32 | 41 | 0 | 64 |
| TOTAL | $24 | $34 | $44 | $N/A | $71 |
| Total Assets | $610 | $623 | $634 | $N/A | $763 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,182 | 3,105 | 3,094 | N/A | 3,126 |
| Accounts payable and accrued liabilities | 39 | 41 | 27 | 1 | 15 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 1,435 |
| Other current liabilities | 209 | 146 | 83 | N/A | 104 |
| TOTAL | $3,430 | $3,292 | $3,203 | $1 | $4,680 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,430 | $3,292 | $3,203 | $1 | $4,680 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 855 | 16 | 16 | 16 | 14 |
| Common Shares | 0 | 10 | 9 | 0 | 8 |
| Retained earnings | -16,495 | -16,345 | -16,229 | -2 | -13,203 |
| TOTAL | $-2,819 | $-2,669 | $-2,570 | $-1 | $-3,917 |
| Total Liabilities And Equity | $610 | $623 | $634 | $0 | $763 |